Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 4Other hematologic neoplasm 3Lymphoid 3Gastrointestinal 3Head & Neck 2Thoracic 1Sarcoma 1Dermatologic 1

Conditions

Vomiting 3Nausea 3Leukemia 2Hematologic Neoplasms 2Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1

Interventions

Aprepitant 7Ondansetron 6Palonosetron 3Granisetron 3Dexamethasone 3dexamethasone 21-phosphate 2Cyclophosphamide 2Calcium Dobesilate 2ramosetron 1dexamethasone acetate 1Tropisetron 1Sugars 1Olanzapine 1Immunoenzyme Techniques 1Drug Therapy 1Doxorubicin 1Control Groups 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Vomiting × Palonosetron × Other hematologic neoplasm × Clear all
NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
401 enrolled 14 charts
Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

NCT01031498 2012-08-07

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

M.D. Anderson Cancer Center

Phase 2 Completed
150 enrolled 7 charts
Other hematologic neoplasm

Hematologic Diseases, Leukemia, Nausea, Vomiting, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed
196 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡